Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
PASD1, a DLBCL-associated canc...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
PASD1, a DLBCL-associated cancer testis antigen and candidate for lymphoma immunotherapy.
Bibliographic Details
Main Authors:
Cooper, C
,
Liggins, A
,
Ait-Tahar, K
,
Roncador, G
,
Banham, A
,
Pulford, K
Format:
Journal article
Language:
English
Published:
2006
Holdings
Description
Similar Items
Staff View
Description
Summary:
Similar Items
Cytolytic T-cell response to the PASD1 cancer testis antigen in patients with diffuse large B-cell lymphoma.
by: Ait-Tahar, K, et al.
Published: (2009)
Cytotoxic T-Cell Response to the Cancer Testis Antigen PASD1 In Multiple Myeloma: PASD1 Peptides for a Generic Vaccine to Treat PASD1-Positive Haematological Malignancies.
by: Campbell, A, et al.
Published: (2010)
DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma.
by: Joseph-Pietras, D, et al.
Published: (2010)
PASD1 is a potential multiple myeloma-associated antigen.
by: Sahota, S, et al.
Published: (2006)
Cytotoxic T-cell response to the PASD1 protein in patients with diffuse large B-cell lymphoma
by: Ait-Tahar, K, et al.
Published: (2009)